Effect of activin on production and secretion of prolactin and growth hormone in cultured rat GH3 cells

European Journal of Endocrinology

Volumn 142, Issue 5, 2000, Pages 506-511

  Tamura, Noriko ^a   Irahara, Minoru ^a   Kuwahara, Akira ^a   Ushigoe, Kenjiro ^a   Sugino, Hiromu ^b   Aono, Toshihiro ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; GROWTH HORMONE; PROLACTIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; HORMONE RELEASE; HORMONE SYNTHESIS; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSCRIPTION REGULATION;

EID: 0034039057     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1420506     Document Type: Article

References (26)

1. Meunier H, Rivier C, Evans RM & Vale W. Gonadal and extragonadal expression of inhibin α. βA, and βB subunits in various tissues predicts diverse functions. Proceedings of the National Academy of Sciences of the USA 1988 85 247-251.
2. Aono T, Kuwahara A, Tamura N, Miyamoto S, Ushigoe K, Azuma K et al. The gene expression of activin receptors in rat pituitary. In Inhibin, Activin and Follistatin, pp 21-27. Eds T Aono. H Sugino & W Vale. New York: Springer-Verlag, 1997.
3. Cameron VA, Nishimura E, Mathews LS, Lewis KA, Sawchenko PE & Vale W. Hybridization histochemical localization of activin receptor subtypes in rat brain, pituitary, ovary, and testis. Endocrinology 1994 134 799-808.
4. Eto Y, Tsuji T, Takezawa M, Takano S, Yokogawa Y & Shibai H. Purification and characterization of erythroid differentiation factor (EDF) isolated from human leukemia cell line THP-1. Biochemical and Biophysical Research Communications 1987 142 1095-1105.
5. Yu J, Shao L, Lemas V, Yu AL, Vaughan J. Rivier J et al. Importance of FSH-releasing protein and inhibin in erythrodifferentiation. Nature 1987 330 765-767.
6. Gonzalez-Manchon C & Vale W. Activin-A, inhibin and transforming growth factor-β modulate growth of two gonadal cell lines. Endocrinology 1989 125 1666-1672.
7. Vale W, River J, Vaughan J, McClintock R, Corrigan A, Woo Wd al. Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature 1986 321 776-779.
8. Ling N, Ying S-Y, Ueno N, Shimasaki S. Esch F, Hotta M et al. Pituitary FSH is released by a heterodimer of β-subunits from the two forms of inhibin. Nature 1986 321 779-782.
9. Bilezikjian LM, Corrigan AZ & Vale W. Activin-A modulates growth hormone secretion from cultures of rat anterior pituitary cells. Endocrinology 1990 126 2369-2376.
10. Billestrup N. Gonzalez-Manchon C, Potter E & Vale W. Inhibition of somatotroph growth and growth hormone biosynthesis by activin in vitro. Molecular Endocrinology 1990 4 356-362.
11. Murata T & Ying S-Y. Transforming growth factor-β and activin inhibit basal secretion of prolactin in a pituitary monolayer culture system. Proceedings of the Society for Experimental Biologn and Medicine 1991 198 599-605.
12. Kitaoka M, Kojima I & Ogata E. Activin-A: a modulator of multiple types of anterior pituitary cells. Biochemical and Biophysical Research Communications 1988 157 48-54.
13. Tashjian AH Jr. Bancroft FC & Levine L. Production of both prolactin and growth hormone by clonal strains of rat pituitary tumor cells, Journal of Cell Biology 1970 47 61-70.
14. Yajima Y & Saito T. The effects of hypothalamic extracts and TRH on growth hormone production of GH3 cells in culture. Acta Endocrinologica 1983 104 287-294.
15. Zhang K, Kulig E. Jin L & Lloid RV. Effects of estrogen and epidermal growth factor on prolactin and pit-1 mRNA in GH3 cells. Proceedings of the Society for Experimental Biology and Medicine 1993 202 193-200.
16. Missale C, Castelletti L. Boroni F, Memo M & Spano P. Epidermal growth factor induces the functional expression of dopamine receptors in the GH3 cell line. Endocrinology 1991 128 13-20.
17. Missale C, Boroni F, Sigala S, Zanellato A, Toso RD, Balsari A et al. Nerve growth factor directs differentiation of the biopotential cell line GH-3 into the mammotroph phenotype. Endocrinology 1994 135 290-298.
18. 3) expresses type I and type II receptors and other cell surface binding protein(s) for transforming growth factor-β. Journal of Biological Chemistry 1995 270 770-774.
19. Moustakas A, Takumi T, Lin HY & Lodish HF. GH3 pituitary tumor cells contain heteromeric type I and type II receptor complexes for transforming growth factor-β and activin-A. Journal of Biological Chemistry 1995 270 765-769.
20. Chomczynski P & Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 1987 162 156-159.
21. MacComick A, Wu D, Castrillo JL, Dana S, Strobl J. Thompson EB et al. Extinction of growth hormone expression in somatic cell hybrids involves repression of the specific trans-activator GHF-1. Cell 1988 55 379-589.
22. Supowit SC, Ramsey T & Thompson EB. Extinction of prolactin gene expression in somatic cell hybrids is correlated with the repression of the pituitary-specific trans-activator GHF-1/Pit-1. Molecular Endocrinology 1992 6 786-792.
23. 3 cells. Molecular Endocrinology 1991 5 1716-1722.
24. Gaddy-Kurten D & Vale W. Activin increases phosphorylation and decreases stability of the transcription factor pit-l in MtTW15 somatotrope cells. Journal of Biological Chemistry 1995 270 28733-28739.
25. Daniels M, Harris PE, James RA. Turner SJ, Dewar JH & Kendall-Taylor P. Effect of recombinant human activin A on growth hormone secretion by human somatotrophinomas in vitro. Journal of Endocrinology 1995 137 529-334.
26. Alexander JM, Jameson JL, Bikkal HA, Schwall RH & Klibanski A. The effects of activin on follicle-stimulating hormone secretion and biosynthesis in human glycoprotein hormone-producing pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 1991 72 1261-1267.